|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | |
| A61K 39/00 | |||
| A61K 39/395 |
| (11) | Patento numeris | 3169362 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15760317.6 |
| Europos patento paraiškos padavimo data | 2015-07-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/040765 |
| Data | 2015-07-16 |
| (87) | Numeris | WO 2016/011260 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201462025371 P | 2014-07-16 | US | |
| 201462043167 P | 2014-08-28 | US | |
| 201462080725 P | 2014-11-17 | US | |
| 201562132709 P | 2015-03-13 | US | |
| 15305830 | 2015-05-29 | EP |
| (72) |
HANOTIN, Corinne, FR
BESSAC, Laurence, FR
CHAUDHARI, Umesh, US
PORDY, Robert, US
SCHWEMMER GIPE, Daniel A., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
Sanofi Biotechnology, 54 rue La Boétie, 75008 Paris, FR |
| (54) | METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA |
| METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA |